BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okumura H, Ueyama M, Shoji S, English M. Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan. Journal of Infection and Chemotherapy 2020;26:611-8. [DOI: 10.1016/j.jiac.2020.01.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Sarpong EM, Sears P, Obi EN. Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States. Infect Dis Ther 2021. [PMID: 34292496 DOI: 10.1007/s40121-021-00480-0] [Reference Citation Analysis]